Replies to post #7015 on Long Term Investment, Biotech & High Yield Dividen

[califax]

NOVAVAX Reports Additional Positive Data from Its Trivalent Seasonal Influenza (VLP) Vaccine Clinical Study in Healthy Adults / Data show significant Neuraminidase Inhibition Antibody Titers in VLP vaccine recipients

08.02.2010 18:43
http://www.finanznachrichten.de/nachrichten-2010-02/16091384-novavax-reports-additional-positive-data-from-its-trivalent-seasonal-influenza-vlp-vaccine-clinical-study-in-healthy-adults-data-show-significant-008.htm